Category:
Venture Capital
Description:
InnoBio is a French venture capital fund, managed by CDC Entreprises subscribed by the FSI and leading international pharmaceutical companies established in France, such as sanofi-aventis, GSK, Roche, Novartis, Pfizer, Lilly, Ipsen, Takeda and Boehringer Ingelheim. The main objective of the fund is to make direct equity and quasi-equity investments in companies that provide innovative technology products and services in the healthcare market.
Location:
France
Paris